SkinMedica TNS Advanced+ Serum review: is it worth it?

What is TNS Advanced+ Serum and who makes it?

TNS Advanced+ is an anti-aging facial serum sold by SkinMedica, a professional skincare brand owned by Allergan Aesthetics — itself part of AbbVie, the pharmaceutical company behind Botox and Juvéderm. SkinMedica products are positioned as physician-dispensed cosmeceuticals, typically sold through dermatologists, med-spas, and authorized online retailers (Dermstore, LovelySkin, SkinMedica.com) rather than drugstores.

The "TNS" in the name stands for Tissue Nutrient Solution, SkinMedica's branded blend built around human fibroblast conditioned media (HFCM) — a mixture of growth factors, cytokines, and matrix proteins secreted by cultured neonatal human dermal fibroblasts. TNS Advanced+ launched in 2019 as the successor to the older TNS Essential Serum, and it is delivered in a two-chamber pump bottle:

• Chamber 1 (TNS-MR): the next-generation growth-factor blend (the brand calls the renewed media "Renessensce Advanced" / RSC).
• Chamber 2: a peptide-and-botanical concentrate including two tripeptides, antioxidants, and algae/plant extracts.

The two phases mix only at the moment you press the pump, the rationale being that the peptide phase and the protein-rich growth-factor phase are more stable stored separately.

It is important to be clear about what this is and is not. TNS Advanced+ is a cosmetic, not an FDA-approved drug. It makes "appearance" claims (the look of lines, texture, firmness), not structural medical claims, which is the legal line cosmetics in the U.S. must stay behind. Nothing here is FDA-reviewed for efficacy.

How is it supposed to work?

The central premise is growth-factor signaling. In living skin, fibroblasts produce growth factors (such as TGF-β, VEGF, and others) that orchestrate collagen and elastin synthesis and tissue repair. Production of these signaling proteins declines with age, which is part of why aging skin makes less collagen. The theory behind growth-factor skincare is that applying a media rich in these proteins topically nudges resident skin cells to behave "younger" — making more collagen and elastin and improving texture and tone.

The supporting actives target the same goal through better-established routes:

• Peptides (signal peptides like the tripeptides in chamber 2) are short amino-acid chains that can act as messengers telling skin to produce more matrix proteins, and some have modest evidence for fine-line improvement.
• Antioxidants (vitamin E / tocopheryl acetate, polyphenol-bearing botanical extracts) help neutralize free radicals that drive photoaging.
• Humectants and emollients (glycerin, pentylene glycol, shea-derived esters) hydrate and smooth, which alone temporarily softens the look of fine lines.

There is a real, unresolved scientific caveat at the heart of the growth-factor pitch: growth factors are large molecules, and large proteins penetrate intact skin poorly (DermNet NZ; Dermatology Times). How much of the active protein actually reaches living fibroblasts in the dermis — versus sitting on the surface — is genuinely uncertain. Skin-barrier disruption (microneedling, post-procedure) increases penetration, which is partly why these products are marketed heavily for post-treatment use. For intact, healthy skin, the mechanism is more plausible than proven.

What does the clinical evidence actually show?

This is where TNS Advanced+ separates from most "growth factor" serums: it has a published, peer-reviewed, randomized controlled trial — though one funded by its own maker.

The pivotal study (*Dermatology and Therapy*, 2022; PMID 36374431) was a 24-week, double-blind, randomized, placebo-controlled, split-face crossover trial: each subject applied the active serum to one side of the face and a placebo vehicle to the other for the first 12 weeks, after which the placebo side crossed over to active treatment. Sixty-eight subjects aged 37–70 (Fitzpatrick I–V) enrolled and 66 completed it. Investigators graded photodamage parameters using validated scales. The reported mean improvements from baseline were:

Some changes (fine lines, tactile roughness) reached statistical significance versus baseline as early as week 2. On a patient self-perception scale, subjects reported feeling a median of 6 years younger at week 12 (PMID 36374431).

How should you read these numbers? A roughly 30% improvement in the *appearance* of fine lines over six months is a genuine, measurable cosmetic effect — but a few things temper it:

1. The funder is the maker. Allergan Aesthetics (AbbVie) funded the study and most authors were AbbVie employees (PMID 36374431). Industry-funded cosmetic trials systematically report more favorable outcomes. This is not fraud — it is a known bias that lowers the weight you should give the result.
2. No active comparator. The serum beat a placebo vehicle, not tretinoin or vitamin C. So the trial proves it does *something* better than moisturizer-alike, not that it beats cheaper proven actives.
3. The deepest wrinkles barely moved. Coarse wrinkles and sagging improved only single digits — the headline number is driven by fine lines, the easiest parameter to shift with any well-formulated hydrating serum.
4. The category as a whole is thin. Independent reviews and dermatology references repeatedly note that growth-factor skincare evidence is dominated by small, manufacturer-run studies, with no large independent trials and no head-to-head data establishing superiority over retinoids (Skin Type Solutions; DermNet NZ).

Bottom line on evidence: better-supported than almost any competing growth-factor serum, but still modest, single-study, and conflicted.

What are the key ingredients?

The full INCI list (per the product's published label) leads with: Water, Pentylene Glycol, Human Fibroblast Conditioned Media, Glycereth-7 Triacetate, Shea Butter Ethyl Esters, Glycerin, Ethoxydiglycol, Lactococcus Ferment Lysate, Whey Protein, Chlorella Vulgaris Extract, Saccharide Isomerate, Trifluoroacetyl Tripeptide-2, Dimer Tripeptide-43, Hydrolyzed Linseed Extract, Vitis Vinifera (Grape) Flower Cell Extract, Apple Fruit Extract, Tocopheryl Acetate, plus standard texture and preservative ingredients (xanthan gum, phenoxyethanol, EDTA).

The actives that matter:

• Human Fibroblast Conditioned Media — the flagship growth-factor blend. High on the list (3rd), suggesting meaningful concentration, but the exact growth-factor content is proprietary and unstandardized, so you cannot verify potency batch to batch.
• Trifluoroacetyl Tripeptide-2 ("Progeline") — a peptide marketed for improving elasticity/firmness; some manufacturer data, limited independent evidence.
• Dimer Tripeptide-43 — a second signal peptide; this two-peptide approach is the "Advanced+" upgrade over the older single-peptide TNS Essential.
• Whey protein and Lactococcus ferment lysate — protein/ferment ingredients contributing additional peptides and conditioning.
• Chlorella vulgaris (green microalgae) and botanical extracts — antioxidants and claimed collagen/elastin support.
• Tocopheryl acetate (vitamin E) — antioxidant, though the acetate ester is less active than free tocopherol.

Notably absent: there is no retinoid and no high-dose vitamin C (L-ascorbic acid) here — the two ingredients with the strongest independent anti-aging evidence. TNS Advanced+ is meant to complement, not replace, those.

Who is it best for, and who should skip it?

Reasonable fit if you:

• Have early-to-moderate fine lines and want a well-formulated, gentle serum that layers cleanly under sunscreen and pairs with a retinoid used on alternate nights.
• Cannot tolerate retinoids (sensitivity, pregnancy considerations) and want a non-irritating active to fill the gap. Note: discuss any product with your OB before use in pregnancy; growth factors specifically lack pregnancy safety data.
• Are recovering from an in-office procedure (laser, microneedling, peels) and a dermatologist has recommended a growth-factor serum to support the healing-phase look — a common, plausible use case.
• Have the budget and want the growth-factor serum with the most published support.

Better to skip if you:

• Have a personal history of skin cancer, precancerous lesions, or active skin malignancy. Growth factors are pro-proliferative by design and are not adequately studied in these populations; multiple dermatology sources advise caution and a physician conversation first (Dermatology Times; Skin Type Solutions).
• Are on a budget and don't yet use the proven basics. If you're not already using daily SPF, a retinoid, and ideally a vitamin C, your money buys far more anti-aging return there first.
• Object to human-cell-derived ingredients on ethical or regulatory grounds — HFCM is restricted in the EU and permitted in the U.S.; it is a values question as much as a safety one.

Is it safe? Side effects and the growth-factor controversy

For routine cosmetic use, the safety record is reassuring. The serum is fragrance-free in the irritant sense and is generally well tolerated; the most common issues are mild, transient redness, stinging, or breakouts, mostly tied to the peptide/preservative phase, not unique to this product.

The bigger, legitimate debate is theoretical cancer risk from topical growth factors. The concern is biologically coherent: growth factors drive cell proliferation, and uncontrolled proliferation is a hallmark of cancer; some skin cancers carry growth-factor receptors. A 2014 lawsuit raised exactly this concern about a growth-factor product; it was dismissed in 2018, and no case of skin cancer has been causally linked to a cosmetic growth-factor serum in the published literature (Dermatology Times). The reassurance rests on two facts: the concentrations are low, and growth factors are large molecules that penetrate intact skin poorly — the same limitation that tempers the efficacy claim cuts the risk too. The honest summary: no demonstrated harm in healthy users, genuine uncertainty for people with skin-cancer risk factors, and an absence of long-term human safety data. This is a "discuss with your dermatologist if you're high-risk" product, not a "safe for everyone, settled science" product.

How do you use it, and how does it compare to TNS Recovery Complex?

Apply twice daily (AM and PM) to clean, dry skin before heavier moisturizers. Because chamber mixing happens at the pump, use it reasonably soon after dispensing. A morning routine should always finish with broad-spectrum SPF — without it, you forfeit most anti-aging benefit regardless of serum.

Within SkinMedica's line:

• TNS Recovery Complex is a single-phase, growth-factor-dominant gel (often cited at ~90%+ TNS), aimed at post-procedure recovery and barrier support. Simpler, growth-factor-centric.
• TNS Advanced+ is the dual-chamber, "everything" version — growth factors *plus* two peptides, antioxidants, and botanicals — positioned as the premium daily anti-aging serum.

If your goal is post-treatment recovery, Recovery Complex is the targeted choice; for general daily anti-aging, Advanced+ is the broader formula (dermavenue; LovelySkin).

Cost and value: is it worth it?

TNS Advanced+ typically retails around $290–$295 for a 1 fl oz (28.4 g) bottle from authorized sellers (SkinMedica.com, Dermstore, LovelySkin), with occasional third-party listings lower (around $258 at Walmart). At twice-daily use a bottle lasts roughly 6–10 weeks, putting real-world cost in the range of $1,200–$2,000 per year.

That is the crux of the value problem. The clinical effect is real but modest and was measured only against placebo — while the most evidence-backed anti-aging actives are dramatically cheaper:

• Prescription tretinoin / OTC retinol has decades of independent, peer-reviewed evidence for wrinkles and photoaging, for a tiny fraction of the price.
• Vitamin C (L-ascorbic acid) and daily broad-spectrum SPF are both well-supported and inexpensive.

You are paying a substantial premium for a proprietary growth-factor blend whose superiority over those proven actives has never been demonstrated head-to-head. For someone who already has the basics dialed in, has the budget, and wants a gentle complementary serum (especially around procedures), it can be a defensible luxury. For most people optimizing results per dollar, the money is better spent on the proven foundation first.

The bottom line

TNS Advanced+ Serum is one of the better-substantiated growth-factor serums on the market — it has an actual randomized, placebo-controlled trial showing measurable improvement in fine lines and texture over 24 weeks. But three caveats keep it from being a clear recommendation: the pivotal trial was funded and largely authored by the manufacturer, it was never tested against proven actives like retinoids, and the price (~$290 a bottle, well over $1,000 a year) is steep for an effect that is real but modest. It is a legitimate, well-formulated, generally well-tolerated product — best viewed as an optional premium add-on for buyers who already use sunscreen and a retinoid, or who need a gentle serum around in-office procedures, and who can afford it. It is not a substitute for the cheaper, better-proven basics, and people with a history of skin cancer should clear it with a dermatologist first.

*This analysis is educational and not medical advice. Consult a dermatologist about your skin, especially with any history of skin cancer, precancerous lesions, or during pregnancy.*